AstraZeneca (United Kingdom)-ko ikertzaileekin lankidetzan egindako argitalpenak (5)

2023

  1. Impact of COPD Exacerbations and Burden of Disease in Spain: AVOIDEX Study

    International Journal of COPD, Vol. 18, pp. 1103-1114

2021

  1. Real-world study in severe eosinophilic asthma patients refractory to anti-IL5 biological agents treated with benralizumab in Spain (ORBE study)

    BMC Pulmonary Medicine, Vol. 21, Núm. 1

2018

  1. Characteristics of COPD Patients Managed in Respiratory Medicine Departments in Spain, According to GOLD Groups and GesEPOC Clinical Phenotypes

    Archivos de Bronconeumologia, Vol. 54, Núm. 11, pp. 559-567

2017

  1. The variability of respiratory symptoms and associated factors in COPD

    Respiratory Medicine, Vol. 129, pp. 165-172

2009

  1. Study of the burden on patients with chronic obstructive pulmonary disease

    International Journal of Clinical Practice, Vol. 63, Núm. 1, pp. 87-97